BUSINESS● LOWJul 13 · Jul 13, 2026, 1:47 PM
TG Therapeutics (TGTX) Gains as Its Key Drug Exceeded Expectations
Yahoo Finance
TG Therapeutics (TGTX) experienced gains in its stock value. This increase is attributed to the performance of its key drug, which surpassed expectations.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS9m agoWeatherford outlines Q4 revenue of $1.28B-$1.33B with adjusted EBITDA of $270M-$290M while targeting 50% free cash flow conversion in 2027Seeking Alpha TechBUSINESS12m agoBaidu nears 2022 lows as search revenue declines and AI push fails to lift stockSeeking Alpha Tech